In Vitro and in Vivo trypanocidal synergistic activity of N-butyl-1- (4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3- carboxamide associated with benznidazole

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 507-512

  Valdez, Rodrigo Hinojosa ^a   Tonin, Lilian Tatiani Düsman ^b   Ueda Nakamura, Tânia ^b   Silva, Sueli Oliveira ^b   Dias Filho, Benedito Prado ^a,b   Kaneshima, Edilson Nobuyoshi ^b   Yamada Ogatta, Sueli Fumie ^a   Yamauchi, Lucy Megumi ^a   Sarragiotto, Maria Helena ^b   Nakamura, Celso Vataru ^a,b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; KETOCONAZOLE; N BUTYL 1 (4 DIMETHYLAMINO)PHENYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE 3 CARBOXAMIDE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; EPIMASTIGOTE; HEART; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MOUSE; NONHUMAN; ORGAN WEIGHT; PARASITEMIA; PRIORITY JOURNAL; TRYPOMASTIGOTE;

AMPHOTERICIN B; ANIMALS; BODY WEIGHT; CARBOLINES; CELL COUNT; CELL LINE; CHAGAS DISEASE; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG SYNERGISM; HAPLORHINI; HEART; HUMANS; KETOCONAZOLE; LIFE CYCLE STAGES; MALE; MICE; MICE, INBRED BALB C; NITROIMIDAZOLES; SURVIVAL RATE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84455192498     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05575-11     Document Type: Article

References (31)

1. Adesse D, Azzam EM, Meirelles MN, Urbina JA, Garzoni LR. 2011. Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro. Antimicrob. Agents Chemother. 55:203-210.
2. Baba M, et al. 2010. γ-Carboline derivatives as potent and selective inhibitors of bovine viral diarrhea virus (BVDV) replication. Antiviral Res. 86:A29.
3. Benaim G, et al. 2006. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J. Med. Chem. 49:892-899. (Pubitemid 43221637)
4. Brener Z. 1962. Therapeutic activity criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 4:386-396.
5. Cummings KL, Tarleton RL. 2003. Rapid quantification of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129:53-59. (Pubitemid 36703222)
6. El-On L, Bazarsky E, Sneir R. 2007. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator imiquimod. Exp. Parasitol. 116:156-162. (Pubitemid 46602257)
7. Endo HE, Garcia Cortez DA, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. 2010. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Res. Microbiol. 161:534-540.
8. Faúndez M, et al. 2008. Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox. Antimicrob. Agents Chemother. 52:1837-1839. (Pubitemid 351614681)
9. Fivelman QL, Adagu IS, Warhurst DC. 2004. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48:4097-4102. (Pubitemid 39434861)
10. Formagio ASN, et al. 2008. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4- triazol-3-yl) β-carboline derivatives. Bioorg. Med. Chem. 16:9660-9667.
11. Izumi E, Ueda-Nakamura T, Dias Filho BP, Veiga VF Jr, Nakamura CV. 2011. Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat. Prod. Rep. 28:809-823.
12. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715. (Pubitemid 38280314)
13. Kamysz E, et al. 2011. In vitro activity of the lipopeptide PAL-Lys-Lys- NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp. Peptides 32:99-103.
14. Kontoyiannis DP, Lewis RE. 2003. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist. Updat. 6:257-269. (Pubitemid 37493782)
15. Kumar A, Katiyar SB, Gupta S, Chauahan PMS. 2006. Syntheses of new substituted triazino tetrahydroisoquinolines and β-carbolines as novel antileishmanial agents. Eur. J. Med. Chem. 41:106-113. (Pubitemid 43276065)
16. Mbongo N, Loiseau PM, Craciunescu DG, Robert-Gero M. 1998. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani. Acta Trop. 70:239 -245.
17. Messadi AA, et al. 2008. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an invasive care burn unit: a 5-year study, 2000-2004. Burns 34:1098-1102.
18. Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52:1. (Pubitemid 36850074)
19. Paulino M, et al. 2005. The chemotherapy of Chagas' disease: an overview. Mini Rev. Med. Chem. 5:499-519. (Pubitemid 40601640)
20. Pelizzaro-Rocha KJ, et al. 2010. Synergistic effects of parthenolide and benznidazole on Trypanosoma cruzi. Phytomedicine 18:36-39.
21. Pereira MR, et al. 2011. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob. Agents Chemother. 55:3115-3124.
22. Rand KH, Houck HJ, Brown P, Bennett D. 1993. Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob. Agents Chemother. 37:613-615. (Pubitemid 23072613)
23. Rodrigues Coura JR, De Castro SL. 2002. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24. (Pubitemid 135746197)
24. Salomão K, et al. 2010. In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi. Antimicrob. Agents Chemother. 54:2023-2031.
25. Sopirala MM, et al. 2010. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:4678-4683.
26. 24(25) sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 73:199-210.
27. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42:294-307.
28. Urbina JA. 2010. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 115:55-68.
29. Valdez RH, et al. 2009. Biological activity of 1,2,3,4-tetrahydro-β- carboline-3-carboxamides against Trypanosoma cruzi. Acta Trop. 110: 7-14.
30. WHO. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland.
31. WHO/TDR. 2006. Report of the Scientific Working Group on Chagas'Disease, p 7. World Health Organization, Geneva, Switzerland.